WALTHAM, Mass., Jan. 3 /PRNewswire/ --
Thermo Electron Corporation (NYSE: TMO) announced that it will present at the
JPMorgan H&Q 20th Annual Healthcare Conference at 1:30 p.m. (EST) on Monday,
January 7, 2002, at the Westin St. Francis Hotel in San Francisco, California.
Marijn Dekkers, president and chief operating officer of Thermo Electron,
will present an overview of the company with a focus on its life sciences
businesses and, in particular, Thermo's products for increasing productivity
in drug discovery. During the 30-minute presentation, Mr. Dekkers will discuss
Thermo Electron's revenue expectations for 2001, as well as cash operating EPS
goals through 2004.
Mr. Dekkers's presentation will be Webcast live and available for replay
for 14 days thereafter at
http//www.eventsdigital.com/events/jpmhq/healthcare2002, as well as at
http//www.thermo.com - click on "Investors" then "Presentations."
Thermo Electron Corporation is a global leader in providing technology-
based instruments, components, and systems that offer total solutions for
markets ranging from life sciences to telecommunications to food, drug, and
beverage production. The company's powerful technologies help researchers sift
through data to make discoveries that will fight disease or prolong life. They
allow manufacturers to fabricate critical components required to increase the
speed and quality of communications. And they automatically monitor and
control online production to ensure that quality standards are met safely and
efficiently. Thermo Electron, based in Waltham, Massachusetts, reported $2.3
billion in revenues in 2000 and employs approximately 12,000 people worldwide.
For more information on Thermo Electron, visit http://www.thermo.com.
The following constitutes a "Safe Harbor" statement under the Private
Securities Litigation Reform Act of 1995: This press release contains forward-
looking statements that involve a number of risks and uncertainties. Important
factors that could cause actual results to differ materially from those
indicated by such forward-looking statements are set forth under the heading
"Risk Factors" in the company's Annual Report on Form 10-K for the fiscal year
ended December 30, 2000. These include risks and uncertainties relating to:
integration of the company's instrument businesses, the company's guarantee of
obligations of a subsidiary that was spun off, the effect of exchange rate
fluctuations on international operations, potential impairment of goodwill,
the need to develop new products and adapt to significant technological
change, dependence on customers that operate in cyclical industries, the
effect of changes in governmental regulations, and dependence on customers'
capital spending policies and government funding policies. We undertake no
obligation to publicly update any forward-looking statement, whether as a
result of new information, future events, or otherwise.
SOURCE Thermo Electron Corporation
back to top
